European Bioinformatics Institute   Report issue

Academic/Hospital Phase 1
Founded: Saffron Walden United Kingdom (1992)

Organization Overview

First Clinical Trial
2020
NCT04410003
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

European Bioinformatics Institute

Active Ingredients

Drugs in Phase 1 Trials (1)

human fecal microbiota (Reybota) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1